The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.
AlDabbagh, M A; Gitman, M R; Kumar, D; Humar, A; Rotstein, C; Husain, S.
Am J Transplant
; 17(3): 770-781, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-27545492
The immunology of Epstein-Barr virus-induced disease.
Post-transplant lymphoproliferative disease after liver transplantation.
Post-transplant lymphoproliferative disorder prevention: new light on the horizon?
Cutaneous EBV-related lymphoproliferative disorders.
Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
A Solid Mass in the Chest Wall.
EBV in T-/NK-Cell Tumorigenesis.
An adult case of systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorder with severe hepatic dysfunction and megalosplenia.
Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation.
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.